Preparation method of eye drops

A technology of eye drops and solutions, which is applied in the direction of medical preparations with non-active ingredients, medical preparations containing active ingredients, and pharmaceutical formulas, etc., can solve the problems of poor water solubility and increase drug selectivity, and achieve high water solubility, Effect of increasing drug selectivity and strong hygroscopicity

Pending Publication Date: 2021-10-19
陕西省眼科研究所
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The present invention uses sulfobutyl-β-cyclodextrin inclusion voriconazole solution as the main component, which can effectively solve technical problems such as poor water solubility of voriconazole, and the content of the prepared eye drops can still be kept at about 98.3% after two years of storage. The quality is controllable, with high stability and clarity. Animal experiments have shown that it is non-toxic and non-irritating to the ocular surface; drug sensitivity tests have shown that it has obvious bactericidal and bacteriostatic effects on a variety of common fungi in clinical treatment, which can effectively enrich clinical Variety of drugs for the treatment of fungal keratitis, increasing drug selectivity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of eye drops
  • Preparation method of eye drops
  • Preparation method of eye drops

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] This embodiment provides a preparation method of eye drops, the osmotic pressure of the eye drops is 303mOsm / L, the eye drops include voriconazole solution complexed with sulfobutyl-β-cyclodextrin, the drops The content of voriconazole in eye drops is 4mg / mL;

[0030] Described preparation method comprises:

[0031] Step 1, 4g voriconazole is dissolved with 23mL acid solution to obtain solution A; the acid solution is hydrochloric acid solution; the concentration of the acid solution is 0.1mol / L;

[0032] Step 2, dissolving 60g of sulfobutyl-β-cyclodextrin in 400mL of water for injection to obtain solution B;

[0033] Step 3: Add solution A to solution B at a rate of 0.05 mL / s under stirring at room temperature to obtain a mixed system; the room temperature is 20°C to 25°C;

[0034] Step 4. Stir the mixed system described in Step 3 for 3 hours at room temperature to obtain a voriconazole solution clathrated with sulfobutyl-β-cyclodextrin; the room temperature is 20°C ...

Embodiment 2

[0042] This embodiment provides a preparation method of eye drops, the osmotic pressure of the eye drops is 280mOsm / L, the eye drops include voriconazole solution complexed with sulfobutyl-β-cyclodextrin, the drops The content of voriconazole in eye drops is 1mg / mL;

[0043] Described preparation method comprises:

[0044] Step 1, 1g voriconazole is dissolved with 8mL acid solution to obtain solution A; the acid solution is hydrochloric acid solution; the concentration of the acid solution is 1mol / L;

[0045] Step 2. Dissolve 15g of sulfobutyl-β-cyclodextrin in 100mL of water for injection to obtain solution B;

[0046] Step 3. Under the condition of stirring at room temperature, solution A is added to solution B at a rate of 0.25mL / s to obtain a mixed system; the stirring is by ultrasonic stirring;

[0047] Step 4. Stir the mixed system described in Step 3 for 3.5 hours at room temperature to obtain a voriconazole solution clathrated with sulfobutyl-β-cyclodextrin;

[0048...

Embodiment 3

[0053] This embodiment provides a method for preparing eye drops, the osmotic pressure of the eye drops is 320mOsm / L, the eye drops include voriconazole solution complexed with sulfobutyl-β-cyclodextrin, the drops The content of voriconazole in eye drops is 5mg / mL;

[0054] Described preparation method comprises:

[0055] Step 1, 5g voriconazole is dissolved with 30mL acid solution to obtain solution A; the acid solution is hydrochloric acid solution; the concentration of the acid solution is 0.5mol / L;

[0056] Step 2. Dissolve 75g of sulfobutyl-β-cyclodextrin in 500mL of water for injection to obtain solution B;

[0057] Step 3. Under the condition of stirring at room temperature, solution A is added to solution B at a rate of 0.2mL / s to obtain a mixed system; the stirring is by ultrasonic stirring;

[0058] Step 4. Stir the mixed system described in Step 3 for 4 hours at room temperature to obtain a voriconazole solution clathrated with sulfobutyl-β-cyclodextrin;

[0059]...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a preparation method of eye drops, and the eye drops comprise a voriconazole solution clathrated by sulfobutyl-beta-cyclodextrin. The preparation method of the voriconazole solution clathrated by sulfobutyl-beta-cyclodextrin comprises the following steps: 1, dissolving voriconazole with an acid solution to obtain a solution A; 2, dissolving sulfobutyl-beta-cyclodextrin by using water for injection to obtain a solution B; 3, adding the solution A into the solution B under room-temperature stirring or ultrasonic conditions to obtain a mixed system; 4, stirring the mixed system in the step 3 at room temperature to obtain the voriconazole solution included by the sulfobutyl-beta-cyclodextrin. According to the voriconazole oral liquid, the voriconazole solution included by the sulfobutyl-beta-cyclodextrin serves as a main component, the defect that voriconazole is poor in water solubility can be effectively overcome, the voriconazole oral liquid is non-toxic and non-irritant to ocular surfaces and has an obvious sterilization and bacteriostasis effect on various common clinical fungi, the content of the voriconazole oral liquid can still be kept at about 98.3% after the voriconazole oral liquid is placed for two years, and the voriconazole oral liquid has high stability and clarity.

Description

technical field [0001] The invention belongs to the technical field of ophthalmic preparations, and in particular relates to a preparation method of eye drops. Background technique [0002] Fungal keratitis is an infectious corneal disease caused by pathogenic fungi with an insidious course and a high blinding rate. With the widespread use of broad-spectrum antimicrobials, glucocorticoids, and antiviral drugs in clinical practice, the incidence of fungal keratitis in China is increasing year by year. There are as many as 56 genera and 105 species of bacteria that can cause ocular corneal infection. According to epidemiological statistics and retrospective analysis of pathogenic bacteria spectrum, it is found that the pathogenic bacteria of common fungal infections in China are: Fusarium, Aspergillus, Candida, Penicillium and Saccharomyces, of which Fusarium and Aspergillus The genus is the most common pathogen, and the incidence of Alternaria has been increasing in recent ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/08A61K31/506A61K47/69A61K47/36A61P27/02A61P31/10
CPCA61K31/506A61K47/6951A61K47/36A61K9/08A61K9/0048A61P27/02A61P31/10
Inventor 王养正赵娜潘士印杨扬朱秀萍
Owner 陕西省眼科研究所
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products